Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II TrialSD-101 with Pembrolizumab in PD-1…

Overview of attention for article published in Clinical Cancer Research, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

news: 1 news outlet

twitter: 11 X users

Readers on

mendeley: 39 Mendeley

So far, Altmetric has seen 17 X posts from 11 X users, with an upper bound of 316,650 followers.

RT @d_stock07734: $NWBO Sanofi acquired Dynavax for $2.5b. Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B…

$NWBO ASM is 2pm ET tomorrow! Northwest Biotherapeutics, Inc. (the “Company”) is hereby releasing an audio-only link to the Annual Meeting of Stockholders to be held on Monday, December 29, 2025 at 2:00 p.m. Eastern Time (the “Annual Meeting”). https…

$NWBO Buyout on Horizon: Amgen floats $28B offer for rare disease drug maker as Sanofi exits bidding war By Fraiser Kansteiner Dec 12, 2022 https://t.co/7vci1X1ELu

$NWBO TriSalus Life Sciences is conducting a trial which includes cryoablation adopted in several DC vaccine trials conducted by Mayo Clinic. Everything could be connected in a mysterious way. Cryoablation and Arterial Infusion of SD-101 in Combinatio…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 13 additional X posts.